WEST PHARMACEUTICAL SERVICES DANMARK ApS: Financial statements 2017
CVR: 16210714
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
WEST PHARMACEUTICAL SERVICES DANMARK ApS (CVR 16210714) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 521,704,000 and a net result of DKK 375,664,000 compared with DKK 354,406,000 the year before. That is an increase of 0.4% compared with the year before. The profit margin was 72%. Equity in the 2017 report amounted to DKK 2,052,591,000. The solvency ratio was 74.2%. The company had 212 employees in the financial year.
- Revenue
- DKK 521,704,000
- Gross Profit
- DKK 127,463,000
- Profit/Loss
- DKK 375,664,000
- Equity
- DKK 2,052,591,000
- Total Assets
- DKK 2,764,508,000
- Employees
- 212
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 521.7 mio. | 127.5 mio. | 375.7 mio. | 2.1 mia. | 212 |
| 2016 | 519.7 mio. | 142.9 mio. | 354.4 mio. | 2.1 mia. | 192 |
| 2015 | 524 mio. | 151.6 mio. | 257.5 mio. | 1.7 mia. | 208 |
Official annual report
Keep an eye on WEST PHARMACEUTICAL SERVICES DANMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 31, 2017, Heino Jakob Lennartz has left the board of directors of WEST PHARMACEUTICAL SERVICES DANMARK ApS.
WEST PHARMACEUTICAL SERVICES DANMARK ApS has published its annual report for 2016. Revenue came to DKK 519,693,000, and the net result was DKK 354,406,000.
About WEST PHARMACEUTICAL SERVICES DANMARK ApS
WEST PHARMACEUTICAL SERVICES DANMARK ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 1999. The company is registered under the industry Fremstilling af letmetalemballage. The company was previously named WEST PHARMACEUTICAL SERVICES DANMARK A/S and THE WEST COMPANY, DANMARK A/S. The management consists of Peter Thorup Hovgaard. The board consists of Shay Kearns (chair), Charlotte Monfeldt Horsbøll, John Ditlev Larsen and Peter Thorup Hovgaard. The company is owned by West Pharmaceutical Services of Delaware, Inc.. The company has 364 employees (2026). In 2025, the company reported revenue of DKK 1,336,445,000 and a net result of DKK 66,980,000 compared with DKK 11,749,681,000 the year before. Equity in the 2025 report amounted to DKK 265,128,000.